Vericel Profit Margin

Vericel (VCEL) currently reports a profit margin of 7.35% as of March 2026. That compares with 1.25% in the prior-year period — up 488.6% year over year. That is below the Healthcare sector average of 15.52%. Use the charts on this page to explore Vericel's profit margin history and peer comparisons.

Vericel's profit margin increased from 1.25% to 7.35% — a 488.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vericel's profit margin of 7.35% is lower than the Healthcare sector average of 15.52%. That is roughly 52.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Vericel's current 7.35% should be judged against Healthcare norms (sector average: 15.52%) and against VCEL's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 7.35%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.52%. From there, open related valuation or income-statement pages for Vericel, and consider following VCEL for alerts when major investors trade the stock.